The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
New paper from Fournier & Sinclair labs: We find that multiple sclerosis (MS) accelerates neuronal aging & its reversal via OSK-reprogramming preserves vision in an MS mouse model, suggesting new strategies for treating MS & potentially other neurological diseases 🧵… https://t.co/q1PmU7w2BT
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.